Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Says he is 'firmly committed'
Quits over Biden's interview
$1,000 for new parents?
Vegas breaks heat record
Ruling in 'Rust' hearing
Housing slump deepened
Over 1,300 flights canceled
Neverland Ranch threatened
No Parkinson's treatments
RNC's new abortion stance
Pleads guilty in Jan. 6 attack
Oil prices slip
To buy Morphic for $3.2B
Millions without power
Texas-Taiwan trade office
Higher education survey
Napoleon’s pistols sold
13 missing hikers found
‘Rotten egg’ atmosphere
NASCAR launches probe
Cape Town homes destroyed
Tanks storm Gaza City
VP pick likely this week
New fertility pill sparks hope
Olympic roster announced
Beryl downgraded
Military land deals review
Violent holiday weekend
New bird flu study
TSA sets screening record
Bloomberg donates $1B
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Ozempic and Cancer Risks
What to know about new study showing weight loss drugs can lower cancer risk
Clinical studies show users of the medications can lose between 5% and 20% of their body weight over time. The study authors wrote that more research is needed to determine exactly how and why GLP-1 drugs may contribute to a lower risk of obesity-associated cancers.
Ozempic and Related Drugs May Reduce Cancer Risks, Study Claims
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
Healthline
2d
GLP-1 Drugs Like Ozempic May Reduce Risk of These 10 Cancers
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...
The American Journal of Managed Care
3d
GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes
Among patients with type 2 diabetes, glucagon-like peptide 1 (GLP-1) receptor agonists reduced their risk of obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback